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Abstract: 
 
Acetylcholine is a ligand for both acetylcholinesterases and nicotinic acetylcholine receptors. 
Hence, at least some local sequence and structural similarities between the acetylcholinesterases 
and the receptors which recognize acetylcholine (ACh) might be expected. Peterson [2] produced 
an alignment of the ACh binding region between these two types of ACh–binding molecules, 
featuring a number of well conserved residues. The extent of this region of sequence similarity 
suggests the possible existence of a common ancenstral ACh binding module. To attempt to 
further validate Peterson′s sequence alignment we have built a homology model of the ACh 
binding domain of the human neuromuscular nicotinic acetylcholine receptor based on the 
structure of acetylcholinesterase from Torpedo californica. Using this 3–D model we have 
examined the residues which were previously shown to interact with the endogenous ligand by 
various methods (mapping, site–directed mutagenesis). The consistency of such data with the 
model provides further support for a structural similarity and possibly a divergent evolutionary 
relationship between the ACh–binding domains of these two classes of proteins. Results suggest 
that this model may be able to contribute to an understanding of the structure and function of the 
ACh receptor. Using this case as an example, we propose that 3–dimensional computer modeling 
can be used as a tool to evaluate distant homologies when adequate experimental data (e.g., site–
directed mutagenesis) is available. 
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Article: 
 
Introduction 
 
Along with exon shuffling, gene duplication and subsequent divergence is a fundamental 
mechanism of protein evolution. Proteins or protein modules derived from a common ancestor 
can accumulate numerous point mutations leading to homologous proteins with varying degrees 
of sequence similarity, in some cases so low as to be insignificant despite conserved structural 
features. A number of techniques have been developed in order to evaluate such potential distant 
homologies, including the comparison of patterns of conserved sequence motifs in multiple 
sequence alignments, and the method of “inverse folding”, which can be applied when at least 
one of the sequences has a known crystal structure [1]. When there is sufficient sequence 
similarity to at least permit a motif-based alignment of the protein sequences, there is another 
way to evaluate such distant relationships that has not been widely used. One can evaluate the 
potential homology by examining the consistency between the 3-D protein model based on the 
proposed alignment and the existing biochemical data, if that data is sufficiently specific in 
relation to the position of amino acid side chains and ligand or substrate binding sites. In this 
paper, we will use the method which we call structural evaluation of distant homology (SEDH), 
to assess a proposed relationship between the nicotinic acetylcholine receptor (nAChR) and 
acetylcholinesterase (AChase). We will demonstrate the approach by mutating a part of the 
substrate binding domain of acetylcholinesterase (a known 3-D structure) into the corresponding 
region of the nicotinic acetylcholine receptor ligand binding domain, based on an alignment 
previously proposed by Peterson [2]. We will show that the consistency of the model with known 
ligand binding data supports the proposed structural relationship. 
 
Acetylcholine (ACh) is a peripheral and central nervous system neurotransmitter that acts at 
several types of ACh receptors, viz. muscarinic and nicotinic. After its action acetylcholine is 
acted upon by the extracellular enzyme acetylcholinesterase (AChase) whose biological role is 
termination of the impulse at the nerve endings by rapid hydrolysis of ACh. The nicotinic ACh 
receptor (nAChR) belongs to the ligand gated ion channel (LGIC) superfamily of proteins. 
nAChR is the most well studied receptor to date within this large family and is thus a prototype 
for understanding the binding of neurotransmitter to the receptor and the subsequent structural 
changes of the receptor. The musarinic ACh receptors, nAChRs and the AChases share the 
primary biological function of interacting with the acetylcholine molecule.[2] Therefore there is 
reason to expect that they may have some structural features in common, such as certain amino 
acid residues to which ACh binds. 
 
 
Figure 1: Comparison of AChase and nAChR sequences (after Peterson, 1989 [2]). Conserved residues are shown 
in red (in several cases they are offset by one position as indicated). In nAChR, residues involved in agonist binding 
are shown in green and those involved in antagonist binding are shown in blue. Amino acid Y190, involved in both 
agonist and ant agonist binding, is shown in cyan. Amino acids involved in ACh binding in AChase are colored in 
magenta. Amino acid Y130 in AChase is conserved and takes part in binding. 1: Torpedo californica 2: Torpedo 
marmorata 3: Mouse 4: Human 
 
The alignment presented by Peterson shows consensus residues among these two types of protein 
sequences.[2] A slightly truncated version of Peterson’s alignment of the region of sequence 
similarity is shown in Figure 1. This region contains most of the residues involved in substrate 
binding in AChase and AChR. Based on this information we ask the question: can the known 3-
D structure of the Torpedo californica AChase from the Brookhaven protein data bank (code 
1ace.pdb) be mutated to give a resonable nAChR model that is consistent with the experimental 
data (i.e. amino acid residues involved in ACh binding)? 
 
Structure of AChases 
 
Within the acetylcholinesterase family, the most well studied members have been the proteins 
from Torpedo californica and Torpedo marmorata, where AChase exists in the form of a 
homodimer consisting of about 540 amino acids. The AChase structure has been resolved by X-
ray crystallography at 2.8 Å.[3] AChase has a deep, narrow cavity 20 Å long in the center of the 
homodimer, also known as the “active site gorge”.[4] An extensive lining made of aromatic 
residues (including Y70, W84, W114, Y121, Y130) forms the binding pocket for the quaternary 
amine which permits different possible orientations for ACh and various sites for agonist and 
antagonist interactions. The model proposed by J. Sussmann et al.[3] features an oxyanion hole 
formed by the main chain nitrogens of G118, G119 and A201 (not shown in the figure) which 
interact with the carbonyl oxygen of ACh. The conserved G117 and G118 probably also play a 
role in making the chain very flexible, facilitating the binding for its interaction.[3] (Figure 2). 
 
 
Figure 2. Interaction between ACh and AChase in the experimental (X-ray) AChase crystal structure (1ace.pdb). 
The peptide backbone is shown as a Ca trace. ACh is shown in red without hydrogens. The side chains of some 
important residues that influence binding or interact with ACh are shown (1-7).  1:Y70  2:W84  3:W114  4:G118  
5:G119  6:Y121  7:Y130 
 
Structure of nAChR 
 
The nAChR is a transmembrane protein consisting of four homologous subunits, α2ßγδ. These 
subunits are arranged in the shape of a torus with a centrally located ion channel. The subunits 
are structurally related, implying that they may have evolved from a common ancestor.[5] 
Ligands of various structural classes are proposed to bind to the large region on the extracellular 
receptor surface towards the N-terminal end, i.e. the a subunit. 
 
Residues Involved In Ligand Binding to nAChR: Experimental Data 
 
Among these nAChR subunits mainly the a subunits have cholinergic binding sites. Some of 
these binding sites are different for agonists and competitive antagonists, as shown by site-
directed mutagenesis and mapping.[6,8] The two main ligand binding segments are 134-153 and 
181-200.[9] 
 
Site-directed mutagenesis and photo-affinity labelling studies show that the antagonist binding 
site (e.g. for α-Bungarotoxin) is not a single residue or a continuous segment but rather 
discontinuous short segments (C142, H186, V188, Y189, Y190, P194, D195, Y198),[6-8] 
probably folded together within the AChR structure.[9] Residues involved in agonist binding are 
Y190, C192, C193, Y198.[6,8] 
 
Thus residues involved in binding lie primarily within the α subunit including and flanking the 
region of the two cysteines 192 and 193 which form a disulfide bond, creating an unusual cis-
peptide linkage.[10, 11] These two cysteines are conserved in all a subunits of the nicotinic 
acetylcholine receptors.[12] In the past, theoretical calculations have been done which have 
predicted that the L-Cys-L-Cys peptide bond can occur only in a cis-peptide form, [13, 14] 
which is supported by X-ray data on model peptides.[10] It has been suggested this Cys-Cys 
bond may act as a molecular switch to control receptor activation. Furthermore since proline 
residues have been observed to have a higher probability of having the cis isomer of the 
preceeding peptide bond compared to other residues,[15] the peptide bond between Cys-193 and 
Pro-194 has been suggested to be in the cis form.[8] Thus there is the potential for at least one or 
possibly two consecutive cis-peptide bonds in this region of AChR. These potential cis peptide 
bonds must be given due consideration when modeling this region of the AChR. 
 
Materials and Methods 
 
Sybyl 6.04 (Tripos Associates, St. Louis, MI 63144-2913) was used to model the receptor 
protein. The AChase structure from Torpedo californica containing the ACh molecule was 
obtained from the Brookhaven Protein data bank (PDB file 1ace), figure 2. The MUTATE 
command was used to mutate the residues between amino acids 61 and 151 according to the 
human neuromuscular nAChR. The rest of the molecule was truncated using the SPLIT 
command. Residues were renumbered from 133 to 223, to correspond with the nAChR sequence. 
Possibly due to an unusual bend in the protein backbone around position 198 involving proline 
197 (not present in AChase), the phenyl ring of tyrosine 198 was not oriented to fit in the protein 
globular structure and faced the side opposite to that of ACh. The protein backbone structure 
between the residues Pro 197 and Asp 200 was thus remodeled using the BIO LOOP feature. 
From the protein model obtained, two versions were made, one containing a cis peptide bond 
between Cys 192 and Cys 193 (mono-cis) and the other containing two cis peptide bonds, 
between Cys192-Cys193 and between Cys 193-Pro 194 (di-cis). Both the protein strucutres were 
separately minimized using the following procedure: the amino acids Cys 192 to Pro 194 were 
defined as the ‘hot region’ using the function ANNEAL in Sybyl. A ‘hot radius’ of 4.5 Å and an 
‘interesting region’ of 10 Å was defined. Minimization was carried out using steepest descent 
using KOLLMAN_ALL atom force field. The ACh molecule and the backbone was then defined 
as AGGREGATE and only the side chains were minimized using the steepest descent method 
with the KOLLMAN_ALL atom force field. Slowly the constraints were relieved and the entire 
molecule was minimized using the KOLLMAN_ALL atom force field, using the conjugate-
gradient method with KOLLMAN charges, a non-bonded cutoff of 8 Å, 1,4-scaling equal to 0.5 
and DE of 0.1kcal/mol. The residues which assist in agonist binding and those involved in the 
interaction with the competitive antagonists are shown in figure 3. 
 
 
Figure 3. Locations of known ACh-interacting residues in the nAChR model. The peptide backbone is shown as a 
Ca trace. ACh is shown in red without hydrogens. Residues which have been shown to interact with agonist ligands 
are numbered below as 5-7, 10 whereas residues numbered below as 1-5, 8, 9 have been shown to interact with 
antagonist ligands. The color scheme for the ligands is the same as that used in figure 1. In this model, all these 
residues clearly cluster around the ACh molecule, consistent with experimental results (see text). Residues C192, 
C193 and P194 have cis peptide bonds between them (see figure 4).  1:C142  2:H186  3:V188  4:T189  5:Y190  
6:C192  7:C193  8:P194  9:D195  10:Y198 
 
Results and Discussion 
 
We confirmed the alignment with the BESTFIT program [16] (gap weight 1.5/2.5, gap length 
0.3/.25) using the sequences of Torpedo californica AChase versus those of Torpedo and human 
AChR. This gave pairwise alignments that were very close to Peterson’s alignment in the region 
of interest (between amino acids T133 and L223). After minimization of the mono-cis and di-cis 
protein fragments we found that the protein with two cis peptide bonds (di-cis) was more stable 
by >5 kcal/mol, than the protein with only one cis peptide bond (mono-cis) between the two 
cysteines forming a disulfide bond. We also made another model (not shown) ditrans with trans 
peptide bonds between Cys192-Cys193-Pro194 which was also >5 kcal/mol higher in energy 
relative to the di-cis model. Considering the energy differences we concluded that the di-cis 
model is a more valid representation of the active domain, a result consistent with earlier 
observations.[9] A backbone fit of the AChR model to the AChase enzyme gave a weighted root 
mean squared difference of 1.6945 Å. Root mean square difference of the backbone of the two 
versions of the AChRs was 0.4188 Å which differed only at the region between Cys 192 and Pro 
194 (Figure 4). Among all the interactive residues within the AChR, only one ligand-binding 
residue has been mutated from the Torpedo californica to the human spieces i.e., Y189T. 
However from the model even the side chain of threonine 189 is seen in close contact with the 
ACh molecule. 
 
 
Figure 4. Stereoview comparing the two versions of the protein model involving the Cys-Cys-Pro sequence, and the 
potential cis-peptide bonds (highlighted in yellow). The mono-cis model is shown in red and the di-cis model is 
shown in green. The amino and the carboxy ends of the fragments are denoted with the letters N and C respectively. 
The models differ only in the peptide bond between Cys 193 and Pro 194. Both the mono-cis model and the di-trans 
model (not shown) are >5kcal/mol higher in energy relative to the di-cis model. 
 
The idea was then to test this model by comparing with the experimental data available in the 
literature, such as site-directed mutagenesis. Many experiments have been performed in the past 
[7-13] where ligand binding sites of the AChR were identified. An attempt was made to 
rationalize the location and function of the binding sites to those given by the model, in order to 
validate any possible distant homology. It is immediately obvious from the model that, as shown 
in figure 3, all the residues previously shown to interact with cholinergic ligands are clustered in 
the immediate vicinity of the predicted ACh binding site. This suggests that the model is at least 
qualitatively correct. 
 
Furthermore, the model can account for specific changes in activity and building associated with 
specific amino acid mutations. By mutagenesis Chaturvedi et. al.[8] and O’Leary et. al.[17] have 
indicated that the aromaticity of the Tyr 190 and Tyr 198 of nAChR were important since they 
form an electronegative subsite through the formation of a tyrosinate anion which could attract 
the positive nitrogen of acetylcholine. This is clearly seen in the model where the aromatic rings 
and their hydroxyl groups face the nitrogen and interact with it. In the AChase structure 
(1ace.pdb) the glycines 117, 118 and 119 are close to the ACh molecule, which correspond to 
T189 and Y190 of AChR in the alignment. The model also correctly predicts that Cys 192, Cys 
193 and Pro 194 in AChR form a turn at the tip of the beta sheet as pointed out earlier by 
Chaturvedi et. al.[8] The rigid conformation induced by the three amino acids comprising the 
disulfide bridge and the cis form of proline (as shown in Figure 4) may uniquely contribute to the 
ability of this region of the nAChR to bind ligands and contribute in the process of channel 
gating.[17] 
 
The sidechains of His 186, Val 188 and Asp 195 in nAChR point toward the ligand in the 
binding domain in this model. Since they are quite a distance (>6 Å) from ACh, they are not 
involved in agonist binding but could be readily involved in binding larger molecules like α-
Bungarotoxin, which again, is precisely consistent with the experimental data [7, 9]. Mutations 
of H186A, V188T probably decrease the sidechain length and branching required for binding of 
the antagonist α-Bungarotoxin to its binding site. 
 
The consistency of the model with the experimental results suggests that these two classes of 
ACh-binding proteins do have some common structural features, supporting the possibility that 
their ligand binding domains may have evolved from a common ancestor. The results suggest 
that the Torpedo AChase protein structure in the Brookhaven protein data bank (figure 2) is a 
reasonable starting point for homology modeling of the ligand binding domain of the human 
ACh receptor (figure 3). 
 
With this example, we have illustrated the approach of this method, which we have tentatively 
called structural evaluation of distant homology (SEDH). When adequate biochemical data 
(mutagenesis etc.) are available, this method may complement existing approaches like inverse 
folding, as a tool for validating speculative homology models. 
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